Open AccessFeasibility of Short-Term PrEP Uptake for Men Who Have Sex With Men With Episodic Periods of Increased HIV Risk
Author(s) -
James E. Egan,
Ken Ho,
Ron Stall,
Moe T. Drucker,
Ryan Tappin,
Craig W. Hendrix,
Mark A. Marzinke,
Steven A. Safren,
Matthew J. Mimiaga,
Christina Psaros,
Steven A. Elsesser,
Kenneth H. Mayer
Publication year - 2020
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002382
Subject(s) - men who have sex with men , emtricitabine , medicine , pre exposure prophylaxis , human immunodeficiency virus (hiv) , observational study , adverse effect , recreational drug use , family medicine , demography , viral load , antiretroviral therapy , syphilis , sociology
Pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir disoproxil fumarate is efficacious in reducing HIV acquisition. For some gay, bisexual, and other men who have sex with men (MSM), daily ongoing PrEP may be unsuitable for use as a long-term prevention strategy because of episodic risk, cost issues, or concerns about the biological consequences of medication.